These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36610230)

  • 1. Anosognosia in HD: Comparison of self-report and caregiver ratings with objective performance measures.
    Hughes SB; Churchill E; Smirnova A; Hall A; Culbert B; Snell C; Wright BA; Gilbert PE; Corey-Bloom J
    Parkinsonism Relat Disord; 2023 Feb; 107():105272. PubMed ID: 36610230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anosognosia Is Associated With Greater Caregiver Burden and Poorer Executive Function in Huntington Disease.
    Wibawa P; Zombor R; Dragovic M; Hayhow B; Lee J; Panegyres PK; Rock D; Starkstein SE
    J Geriatr Psychiatry Neurol; 2020 Jan; 33(1):52-58. PubMed ID: 31213121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Anosognosia on Clinical and Patient-Reported Assessments of Psychiatric Symptoms in Huntington's Disease.
    Isaacs D; Gibson JS; Stovall J; Claassen DO
    J Huntingtons Dis; 2020; 9(3):291-302. PubMed ID: 32925080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a performance-rating method to assess awareness of cognitive functioning in Huntington's disease.
    Hergert DC; Haaland KY; Cimino CR
    Clin Neuropsychol; 2020 Apr; 34(3):477-497. PubMed ID: 31322031
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of anosognosia on patient-reported outcomes for psychiatric symptoms and quality of life in Huntington's disease.
    Isaacs DA; Hay KR; Hoadley J; McDonell KE; Brown AE; Wynn A; Claassen DO; Gibson J
    Parkinsonism Relat Disord; 2024 Jun; 123():106969. PubMed ID: 38614044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anosognosia and Memory Encoding in Huntington Disease.
    Considine CM; Hughes S; Sellers Gibson J; Isaacs D; McDonell K; Darby RR; Claassen D
    Cogn Behav Neurol; 2022 Mar; 35(1):40-48. PubMed ID: 35239598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of dementia, anosognosia, and depression in relation to the quality of life of patients with Alzheimer disease: discrepancies between patients and caregivers.
    Conde-Sala JL; Reñé-Ramírez R; Turró-Garriga O; Gascón-Bayarri J; Campdelacreu-Fumadó J; Juncadella-Puig M; Rico-Pons I; Garre-Olmo J
    Am J Geriatr Psychiatry; 2014 Feb; 22(2):138-47. PubMed ID: 23567444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Longitudinal Association Between a Discrepancy Measure of Anosognosia in Patients with Dementia, Caregiver Burden and Depression.
    Perales J; Turró-Garriga O; Gascón-Bayarri J; Reñé-Ramírez R; Conde-Sala JL
    J Alzheimers Dis; 2016 May; 53(3):1133-43. PubMed ID: 27258415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Awareness of deficits and anosognosia in Alzheimer's disease].
    Antoine C; Antoine P; Guermonprez P; Frigard B
    Encephale; 2004; 30(6):570-7. PubMed ID: 15738860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.
    Vaccarino AL; Anderson K; Borowsky B; Duff K; Giuliano J; Guttman M; Ho AK; Orth M; Paulsen JS; Sills T; van Kammen DP; Evans KR;
    Mov Disord; 2011 Apr; 26(5):877-84. PubMed ID: 21370269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural MRI Correlates of Anosognosia in Huntington's Disease.
    Hinkle JT; Wildermuth E; Tong XJ; Ross CA; Bang J
    J Huntingtons Dis; 2024; 13(3):315-320. PubMed ID: 39269851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross-sectional study.
    Migliore S; D'Aurizio G; Maffi S; Ceccarelli C; Ristori G; Romano S; Castaldo A; Mariotti C; Curcio G; Squitieri F
    Brain Behav; 2021 Jul; 11(7):e02151. PubMed ID: 34110097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?
    Banaszkiewicz K; Sitek EJ; Rudzińska M; Sołtan W; Sławek J; Szczudlik A
    J Neural Transm (Vienna); 2012 Nov; 119(11):1361-5. PubMed ID: 22398875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-awareness of motor dysfunction in patients with Huntington's disease in comparison to Parkinson's disease and cervical dystonia.
    Sitek EJ; Sołtan W; Wieczorek D; Schinwelski M; Robowski P; Reilmann R; Guzińska K; Harciarek M; Krysa W; Sławek J
    J Int Neuropsychol Soc; 2011 Sep; 17(5):788-95. PubMed ID: 21729402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of dual-task cognitive interference on gait and turning in Huntington's disease.
    Purcell NL; Goldman JG; Ouyang B; Liu Y; Bernard B; O'Keefe JA
    PLoS One; 2020; 15(1):e0226827. PubMed ID: 31910203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neurofilament light-chain and phosphorylated tau as biomarkers of disease severity in Huntington's disease: Korean cohort data.
    Hwang YS; Oh E; Kim M; Lee CY; Kim HS; Chung SJ; Sung YH; Yoon WT; Cho JH; Lee JH; Kim HJ; Chang HJ; Jeon B; Woo KA; Ko SB; Kwon KY; Moon J; Shin C; Kim YE; Lee JY
    J Neurol Sci; 2023 Sep; 452():120744. PubMed ID: 37541133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer's disease: a 24-month follow-up study.
    Conde-Sala JL; Turró-Garriga O; Piñán-Hernández S; Portellano-Ortiz C; Viñas-Diez V; Gascón-Bayarri J; Reñé-Ramírez R
    Int J Geriatr Psychiatry; 2016 Feb; 31(2):109-19. PubMed ID: 25963296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ideomotor limb apraxia in Huntington's disease: a case-control study.
    Hödl AK; Hödl E; Otti DV; Herranhof B; Ille R; Bonelli RM
    J Neurol; 2008 Mar; 255(3):331-9. PubMed ID: 18305889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington's disease.
    Aiello EN; Solca F; Torre S; Lafronza A; Maranzano A; Bonetti R; Scheveger F; Maffi S; Ceccarelli C; Scocchia M; Casella M; Verde F; Migliore S; Silani V; Ticozzi N; Squitieri F; Ciammola A; Poletti B
    Neurol Sci; 2024 Mar; 45(3):1079-1086. PubMed ID: 37770762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.